[18F]fallypride characterization of striatal and extrastriatal D2/3 receptors in Parkinson's disease

Autor: Adam J. Stark, Christopher T. Smith, Kalen J. Petersen, Paula Trujillo, Nelleke C. van Wouwe, Manus J. Donahue, Robert M. Kessler, Ariel Y. Deutch, David H. Zald, Daniel O. Claassen
Jazyk: angličtina
Rok vydání: 2018
Předmět:
Zdroj: NeuroImage: Clinical, Vol 18, Iss , Pp 433-442 (2018)
Druh dokumentu: article
ISSN: 2213-1582
DOI: 10.1016/j.nicl.2018.02.010
Popis: Parkinson's disease (PD) is characterized by widespread degeneration of monoaminergic (especially dopaminergic) networks, manifesting with a number of both motor and non-motor symptoms. Regional alterations to dopamine D2/3 receptors in PD patients are documented in striatal and some extrastriatal areas, and medications that target D2/3 receptors can improve motor and non-motor symptoms. However, data regarding the combined pattern of D2/3 receptor binding in both striatal and extrastriatal regions in PD are limited. We studied 35 PD patients off-medication and 31 age- and sex-matched healthy controls (HCs) using PET imaging with [18F]fallypride, a high affinity D2/3 receptor ligand, to measure striatal and extrastriatal D2/3 nondisplaceable binding potential (BPND). PD patients completed PET imaging in the off medication state, and motor severity was concurrently assessed. Voxel-wise evaluation between groups revealed significant BPND reductions in PD patients in striatal and several extrastriatal regions, including the locus coeruleus and mesotemporal cortex. A region-of-interest (ROI) based approach quantified differences in dopamine D2/3 receptors, where reduced BPND was noted in the globus pallidus, caudate, amygdala, hippocampus, ventral midbrain, and thalamus of PD patients relative to HC subjects. Motor severity positively correlated with D2/3 receptor density in the putamen and globus pallidus. These findings support the hypothesis that abnormal D2/3 expression occurs in regions related to both the motor and non-motor symptoms of PD, including areas richly invested with noradrenergic neurons. Keywords: Parkinson's disease, Dopamine, Positron emission tomography (PET), Neurodegeneration, Fallypride
Databáze: Directory of Open Access Journals